U.S. FDA Approves Lung Cancer Drug, Adagrasib
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated
Everything about lung cancer is here.
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated
Lung cancer is one of the most common types of cancers all around the world and has the highest death
When the treatment for lung cancer begins, the patients eagerly wait for the completion. But, one of the most common
A study has been conducted by team of doctors from Medanta Gurugram, India that suggests possible increase in non-smokers and
Lung cancer is one of the most deadly diseases that affects both men and women all around the world. It
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small